论文部分内容阅读
目的:探讨比较肾上腺素联合沙丁胺醇与氨茶碱联合沙丁胺醇治疗小儿喘息性疾病的有效性和安全性。方法:将收治的158例小儿喘息性疾病随机分成两组,治疗组80例,对照组78例。治疗组用肾上腺素联合沙丁胺醇,对照组用氨茶碱联合沙丁胺醇,分析其有效性和安全性。结果:治疗组有效率为97.06%,显效率为85.29%;对照组有效率为80.64%,显效率为61.29%,治疗组疗效明显优于对照组,两组比较有统计学意义(P<0.05)。无严重不良反应发生。结论:肾上腺素联合沙丁胺醇治疗小儿喘息性疾病疗效显著,且安全,无不良反应,值得临床推广应用。
Objective: To compare the efficacy and safety of epinephrine combined with albuterol and aminophylline combined with salbutamol in children with wheezing diseases. Methods: 158 cases of infantile wheezing were randomly divided into two groups, 80 cases in the treatment group and 78 cases in the control group. The treatment group with epinephrine combined with albuterol, the control group with aminophylline combined with albuterol, analysis of its effectiveness and safety. Results: The effective rate of the treatment group was 97.06%, the markedly effective rate was 85.29%. The effective rate of the control group was 80.64%, the effective rate was 61.29%. The curative effect of the treatment group was obviously better than that of the control group (P <0.05) ). No serious adverse reactions occurred. Conclusion: Epinephrine combined with salbutamol treatment of asthmatic children with significant efficacy, and safe, no adverse reactions, it is worth promoting the clinical application.